Your Guide to CRISPR & Molecular Diagnostics
Synthego (synthego.com) earns a Brand Analyzer score of 77 out of 100, placing it in the Brand-Ready tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, Synthego ranks in the 92nd percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 93/100, Digital Presence 82/100, Visual Identity 96/100, Messaging Clarity 100/100, Trust Foundation 80/100, AI Discoverability 78/100, Brand Authority 36/100.
Synthego is a biotechnology company founded in 2012 and headquartered in Menlo Park, United States. It provides high-quality, scalable solutions for CRISPR research, molecular biology, and diagnostic workflows. The company offers engineered nucleases, CRISPR base editing tools, GMP-manufactured products, and custom gene editors in mRNA or protein formats. Synthego supports cell and gene therapy development, including IND submission processes, serving researchers, biotech companies, and clinicians.
| Brand Name | Synthego |
|---|---|
| Domain | synthego.com |
| Industry | Healthcare, Technology |
| Founded | 2012 |
| Headquarters | Menlo Park, United States |
| Main Competitors | Integrated DNA Technologies (IDT), Addgene, Horizon Discovery, Twist Bioscience, GenScript, MilliporeSigma (72/100) |
Moz Domain Authority 52/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #549,261 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "High-quality, scalable solutions for CRISPR research, molecular biology and diagnostic workflows." (Meta description: 11 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram, YouTube, GitHub; no detected presence on X (Twitter) - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Synthego scores 37/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Synthego has a weak AI-visibility profile at 37/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (58/100) and its weakest is visibility (26/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #549,261 (Tranco) and a Moz Domain Authority of 52/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Synthego offers engineered nucleases, CRISPR base editing tools, and custom CRISPR gene editors available in mRNA or protein formats. The company provides GMP-manufactured products for clinical applications and molecular biology reagents for research and diagnostic workflows. It also supports cell and gene therapy development pipelines and offers IND submission support services to facilitate regulatory processes for clinical-stage programs.
Sources: Synthego official site
Synthego's main competitors include Integrated DNA Technologies (IDT), Addgene, Horizon Discovery, Twist Bioscience, GenScript. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Synthego official site
Synthego and MilliporeSigma are competitors in Healthcare. Brand Analyzer scores Synthego at 77/100 and MilliporeSigma at 72/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Synthego official site
Synthego is a biotechnology company founded in 2012 and based in Menlo Park, United States. It operates in the healthcare and technology sectors, positioning itself as a partner in CRISPR gene editing and molecular diagnostics. The company focuses on providing high-quality, scalable solutions for CRISPR research, molecular biology, and diagnostic workflows, and supports clinical-stage applications through GMP manufacturing and IND submission assistance.
Sources: Synthego official site
Popular alternatives to Synthego include Integrated DNA Technologies (IDT), Addgene, Horizon Discovery, Twist Bioscience, GenScript. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Synthego official site
Synthego provides engineered nucleases, CRISPR base editing tools, GMP-manufactured biological products, and molecular biology solutions to accelerate cell and gene therapy development. The company produces custom CRISPR gene editors available in mRNA or protein formats for clinical applications, with rapid, high-yield production capabilities. It also supports diagnostic workflows and assists organizations with IND submission processes for regulatory compliance.
Sources: Synthego official site
Synthego has limited AI-search visibility, scoring 37/100 on Brand Analyzer's AI visibility composite (visibility 26, trust 37, recommendation 58). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Synthego official site
Synthego was founded in 2012. Synthego operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Synthego is known for pioneering engineered nucleases and CRISPR base editing technologies. The company is recognized for offering scalable CRISPR research solutions, GMP manufacturing of gene editing tools, and custom CRISPR gene editors in mRNA or protein formats suitable for clinical applications. It is also noted for supporting cell and gene therapy workflows and providing IND submission support to biotech companies and clinicians.
Sources: Synthego official site
Synthego scores 58/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Synthego official site
Synthego's products and services are used by researchers, biotech companies, and clinicians working in the fields of cell and gene therapy, molecular biology, and diagnostics. Its GMP manufacturing and IND submission support specifically serve organizations advancing therapies toward clinical trials. The company's scalable solutions are designed to meet the needs of both early-stage research teams and organizations at more advanced stages of therapeutic development.
Sources: Synthego official site
Synthego can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Synthego official site
Based on available facts, Synthego's popularity among researchers, biotech companies, and clinicians is tied to its scalable CRISPR solutions, GMP manufacturing capabilities, and support for clinical applications including IND submissions. Its offerings of custom CRISPR gene editors in both mRNA and protein formats, combined with high-yield production, make it a practical partner for cell and gene therapy development. No specific usage statistics or market share data are available in the provided facts.
Sources: Synthego official site
Ranked closest to Synthego: Symplast (77/100), Sully.ai (77/100), University of Mississippi Medical Center (UMMC) (77/100), Virtua Health (77/100).
A step up - brands to learn from: Zipline (81/100), Zimmer Biomet (81/100).
Category leader: Dassault Systèmes (95/100).